Cargando…

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report

Cellular therapy for spinal cord injury (SCI) is overviewed focusing on bone marrow mononuclear cells, olfactory ensheathing cells, and mesenchymal stem cells. A case is made for the possibility of combining cell types, as well as for allogeneic use. We report the case of 29 year old male who suffer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichim, Thomas E, Solano, Fabio, Lara, Fabian, Paris, Eugenia, Ugalde, Federico, Rodriguez, Jorge Paz, Minev, Boris, Bogin, Vladimir, Ramos, Famela, Woods, Erik J, Murphy, Michael P, Patel, Amit N, Harman, Robert J, Riordan, Neil H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989319/ https://www.ncbi.nlm.nih.gov/pubmed/21070647 http://dx.doi.org/10.1186/1755-7682-3-30

Ejemplares similares

Combination stem cell therapy for heart failure
por: Ichim, Thomas E, et al.
Publicado: (2010)

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
por: Yang, Wan-Zhang, et al.
Publicado: (2010)

Feasibility investigation of allogeneic endometrial regenerative cells
por: Zhong, Zhaohui, et al.
Publicado: (2009)

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
por: Riordan, Neil H, et al.
Publicado: (2009)

Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects
por: Mikirova, Nina A, et al.
Publicado: (2010)

Exogenous endothelial cells as accelerators of hematopoietic reconstitution
por: Mizer, J Christopher, et al.
Publicado: (2012)

Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?
por: Murphy, Michael P, et al.
Publicado: (2008)

Exosomes as a tumor immune escape mechanism: possible therapeutic implications
por: Ichim, Thomas E, et al.
Publicado: (2008)

Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
por: Rodriguez, Jorge Paz, et al.
Publicado: (2012)

Cord blood in regenerative medicine: do we need immune suppression?
por: Riordan, Neil H, et al.
Publicado: (2007)

Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy
por: Nguyen, Duong Hoang, et al.
Publicado: (2022)

Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
por: Mikirova, Nina A, et al.
Publicado: (2009)

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011)

Lasers, stem cells, and COPD
por: Lin, Feng, et al.
Publicado: (2010)

Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
por: Draganov, Dobrin D., et al.
Publicado: (2019)

Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
por: Draganov, Dobrin D., et al.
Publicado: (2021)

Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic
por: Bockeria, Leo, et al.
Publicado: (2013)

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels
por: Riordan, Neil H., et al.
Publicado: (2019)

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
por: Riordan, Neil H., et al.
Publicado: (2018)

Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
por: Riordan, Neil H., et al.
Publicado: (2021)

Xenon in the treatment of panic disorder: an open label study
por: Dobrovolsky, Alexander, et al.
Publicado: (2017)

Robotic Bronchoscopy for Diagnosis of Suspected Lung Cancer: A Feasibility Study
por: Rojas-Solano, José R., et al.
Publicado: (2018)

Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine
por: Wagner, Samuel C., et al.
Publicado: (2017)

On the Feasibility of Utilizing Allogeneic Bone Blocks for Atrophic Maxillary Augmentation
por: Monje, Alberto, et al.
Publicado: (2014)

Endometrial regenerative cells: A novel stem cell population
por: Meng, Xiaolong, et al.
Publicado: (2007)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
por: Ma, Wenxue, et al.
Publicado: (2011)

Stem Cell Therapy for Autism
por: Ichim, Thomas E, et al.
Publicado: (2007)

Allogenic umbilical cord tissue for temporomandibular joint injuries
por: Aratikatla, Adarsh, et al.
Publicado: (2023)

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia
por: Kumar, Bijender, et al.
Publicado: (2022)

PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
por: Ma, Wenxue, et al.
Publicado: (2012)

The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development
por: Ichim, Thomas, et al.
Publicado: (2011)

Umbilical cord: an allogenic tissue for potential treatment of COVID-19
por: Rodriguez, Hugo C., et al.
Publicado: (2020)

Allogenic Umbilical Cord Tissue as a Scaffold for Ankle Osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023)

Anti-angiogenic effect of high doses of ascorbic acid
por: Mikirova, Nina A, et al.
Publicado: (2008)

Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
por: Wagner, Samuel C., et al.
Publicado: (2015)

Comparison of endometrial regenerative cells and bone marrow stromal cells
por: Wang, Huan, et al.
Publicado: (2012)

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
por: Kellner, Joshua N., et al.
Publicado: (2018)

Umbilical cord blood: A promising source for allogeneic CAR-T cells
por: Liu, Dian-Dian, et al.
Publicado: (2022)

Abstract 23 HLA-Homozygous iPSC from Cord Blood for the Generation of Cardiomyocytes for Allogeneic Cell Therapy to the Heart
por: Becker, Fabienne, et al.
Publicado: (2023)

A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures
por: Ichim, Thomas E, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_bs7kh4bqho036s530bdl087i0q